Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J.
Cbr Laboratories, Inc., Boston, MA, United States
Search 3 grants from Robert Mandle
Search grants from Cbr Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The relationship between host diet, the gut microbiota, and host transcription
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfection
Mucosal Immune Ontogeny and Intestinal Microbiota in Infants
Heparanomics: Structure-Function Relationships
Manipulating MHC Gene Expression in Es Cell Chimeras
Recently added grants:
Top-down modulation of visual processing: mechanisms and functions
Deep Learning Approaches for Personalized Modeling and Forecasting of Glaucomatous Changes
Structure, function and aggregation of lens ?-crystallins by CryoEM
Lens epithelial cell heterogeneity during development
Molecular, cellular, anatomical and neurobiological investigation of melanopsin-expressing corneal innervation, and its role in pain and photophobia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052290-03
Application #
2229597
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (18))
Project Start
1993-08-10
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cbr Laboratories, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1996
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
NIH 1995
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
Comments
Be the first to comment on Robert Mandle's grant